Luteolin reduces Alzheimer's disease pathologies induced by traumatic brain injury

International Journal of Molecular Sciences

Volumn 15, Issue 1, 2014, Pages 895-904

  Sawmiller, Darrell ^a,b   Li, Song ^b,c   Shahaduzzaman, Md ^b   Smith, Adam J ^b   Obregon, Demian ^a,b   Giunta, Brian ^b   Borlongan, Cesar V ^b   Sanberg, Paul R ^b   Tan, Jun ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c DALIAN UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Alzheimer's disease; Amyloidogenesis; GSK; Luteolin; Neuroinflammation; Tauopathy; Traumatic brain injury

Indexed keywords

AMYLOID BETA PROTEIN; GLYCOGEN SYNTHASE KINASE 3; INTERLEUKIN 1BETA; LUTEOLIN; TAU PROTEIN; THIONINE; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN DAMAGE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; MOUSE; NERVE FIBER TRANSPORT; NERVOUS SYSTEM INFLAMMATION; NEUROFIBRILLARY TANGLE; NONHUMAN; PROTEIN PHOSPHORYLATION; RISK FACTOR; SENILE PLAQUE; TAUOPATHY; TRAUMATIC BRAIN INJURY; WESTERN BLOTTING;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BRAIN; BRAIN INJURIES; CYTOKINES; GLYCOGEN SYNTHASE KINASE 3; LUTEOLIN; MICE; TAU PROTEINS; TISSUE DISTRIBUTION;

EID: 84892171607     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms15010895     Document Type: Article

References (33)

1. O'Meara, E.S.; Kukull, W.A.; Sheppard, L.; Bowen, J.D.; McCormick, W.C.; Teri, L.; Pfanschmidt, M.; Thompson, J.D.; Schellenberg, G.D.; Larson, E.B. Head injury and risk of Alzheimer's disease by apolipoprotein E genotype. Am. J. Epidemiol. 1997, 146, 373-384.
2. Guo, Z.; Cupples, L.A.; Kurz, A.; Auerbach, S.H.; Volicer, L.; Chui, H.; Green, R.C.; Sadovnick, A.D.; Duara, R.; DeCarli, C.; et al. Head injury and the risk of AD in the MIRAGE study. Neurology 2000, 54, 1316-1323.
3. Plassman, B.L.; Havlik, R.J.; Steffens, D.C.; Helms, M.J.; Newman, T.N.; Drosdick, D.; Phillips, C.; Gau, B.A.; Welsh-Bohmer, K.A.; Burke, J.R.; et al. Documented head injury in early adulthood and risk of Alzheimer's disease and other dementias. Neurology 2000, 55, 1158-1166.
4. Johnson, V.E.; Stewart, W.; Smith, D.H. Widespread tau and amyloid-Beta pathology many years after a single traumatic brain injury in humans. Brain Pathol. 2012, 22, 142-149.
5. Ikonomovic, M.D.; Uryu, K.; Abrahamson, E.E.; Ciallella, J.R.; Trojanowski, J.Q.; Lee, V.M.; Clark, R.S.; Marion, D.W.; Wisniewski, S.R.; DeKosky, S.T. Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury. Exp. Neurol. 2004, 190, 192-203.
6. Roberts, S.B.; Ripellino, J.A.; Ingalls, K.M.; Robakis, N.K.; Felsenstein, K.M. Non-amyloidogenic cleavage of the beta-amyloid precursor protein by an integral membrane metalloendopeptidase. J. Biol. Chem. 1994, 269, 3111-3116.
7. DeKosky, S.T.; Abrahamson, E.E.; Ciallella, J.R.; Paljug, W.R.; Wisniewski, S.R.; Clark, R.S.; Ikonomovic, M.D. Association of increased cortical soluble abeta42 levels with diffuse plaques after severe brain injury in humans. Arch. Neurol. 2007, 64, 541-544.
8. Gentleman, S.M.; Nash, M.J.; Sweeting, C.J.; Graham, D.I.; Roberts, G.W. Beta-amyloid precursor protein (beta APP) as a marker for axonal injury after head injury. Neurosci. Lett. 1993, 160, 139-144.
9. Goldstein, L.; Fisher, A.; Tagge, C.; Zhang, X.; Velisek, L.; Sullivan, J.; Upreti, C.; Kracht, J.; Ericsson, M.; Wojnarowicz, M., et al. Chronic traumatic encephalopathy in blast-exposed military veterans and a blast neurotrauma mouse model. Sci. Transl. Med. 2012, 4, 134ra160.
10. Tajiri, N.; Kellogg, S.L.; Shimizu, T.; Arendash, G.W.; Borlongan, C.V. Traumatic brain injury precipitates cognitive impairment and extracellular aβ aggregation in Alzheimer's disease transgenic mice. PLoS One 2013, 8, e78851.
11. Shitaka, Y.; Tran, H.T.; Bennett, R.E.; Sanchez, L.; Levy, M.A.; Dikranian, K.; Brody, D.L. Repetitive closed-skull traumatic brain injury in mice causes persistent multifocal axonal injury and microglial reactivity. J. Neuropathol. Exp. Neurol. 2011, 70, 551-567.
12. Tran, H.; LaFerla, F.; Holtzman, D.; Brody, D. Controlled cortical impact traumatic brain injury in 3xTg-AD mice causes acute intra-axonal amyloid-β accumulation and independently accelerates the development of tau abnormalities. J. Neurosci. 2011, 31, 9513-9525.
13. Rezai-Zadeh, K.; Douglas, S.; Bai, Y.; Tian, J.; Hou, H.; Mori, T.; Zeng, J.; Obregon, D.; Town, T.; Tan, J. Flavonoid-mediated presenilin-1 phosphorylation reduces Alzheimer's disease beta-amyloid production. J. Cell. Mol. Med. 2009, 13, 574-588.
14. Zhou, F.; Chen, S.; Xiong, J.; Li, Y.; Qu, L. Luteolin reduces Zinc-induced Tau phosphorylation at Ser262/356 in an ROS-dependent manner in SH-SY5Y cells. Biol. Trace Elem. Res. 2012, 149, 273-279.
15. Chen, X.H.; Johnson, V.E.; Uryu, K.; Trojanowski, J.Q.; Smith, D.H. A lack of amyloid beta plaques despite persistent accumulation of amyloid beta in axons of long-term survivors of traumatic brain injury. Brain Pathol. 2009, 29, 214-223.
16. Stokin, G.B.; Lillo, C.; Falzone, T.L.; Brusch, R.G.; Rockenstein, E.; Mount, S.L.; Raman, R.; Davies, P.; Masliah, E.; Williams, D.S., et al. Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 2005, 307, 1282-1288.
17. Adams, J.H.; Graham, D.I.; Murray, L.S.; Scott, G. Diffuse axonal injury due to nonmissile head injury in humans: An analysis of 45 cases. Ann. Neurol. 1982, 12, 557-563.
18. Geddes, J.F. What's new in the diagnosis of head injury. J. Clin. Pathol. 1997, 50, 271-274.
19. Geddes, J.F.; Whitwell, H.L.; Graham, D.I. Traumatic axonal injury: Practical issues for diagnosis in medicolegal cases. Neuropathol. Appl. Neurobiol. 2000, 26, 105-116.
20. Reichard, R.R.; White, C.L., 3rd; Hladik, C.L.; Dolinak, D. Beta-amyloid precursor protein staining of nonaccidental central nervous system injury in pediatric autopsies. J. Neurotrauma 2003, 20, 347-355.
21. Graham, D.I.; Gentleman, S.M.; Nicoll, J.A.; Royston, M.C.; McKenzie, J.E.; Roberts, G.W.; Griffin, W.S. Altered beta-APP metabolism after head injury and its relationship to the aetiology of Alzheimer's disease. Acta Neurochir. Suppl. 1996, 66, 96-102.
22. Braak, H.; Braak, E.; Bohl, J. Staging of Alzheimer-related cortical destruction. Eur. Neurol. 1993, 33, 403-408.
23. Jellinger, K.A.; Bancher, C. Neuropathology of Alzheimer's disease: A critical update. J. Neural. Transm. Suppl. 1998, 54, 77-95.
24. Chauhan, N.B.; Siegel, G.J.; Feinstein, D.L. Propentofylline attenuates tau hyperphosphorylation in Alzheimer's Swedish mutant model Tg2576. Neuropharmacology 2005, 48, 93-104.
25. Tan, J.; Town, T.; Paris, D.; Mori, T.; Suo, Z.; Crawford, F.; Mattson, M.P.; Flavell, R.A.; Mullan, M. Microglial activation resulting from CD40-CD40L interaction after beta-amyloid stimulation. Science 1999, 17, 2352-2355.
26. Lee, K.K.; Seow, W.T.; Ng, I. Demographical profiles of adult severe traumatic brain injury patients: Implications for healthcare planning. Singapore Med. J. 2006, 47, 31-36.
27. Molgaard, C.A.; Stanford, E.P.; Morton, D.J.; Ryden, L.A.; Schubert, K.R.; Golbeck, A.L. Epidemiology of head trauma and neurocognitive impairment in a multi-ethnic population. Neuroepidemiology 1990, 9, 233-242.
28. Johnson, V.E.; Stewart, W.; Smith, D.H. Traumatic brain injury and amyloid-beta pathology: A link to Alzheimer's disease? Nat. Rev. Neurosci. 2010, 11, 361-370.
29. McKee, A.C.; Stern, R.A.; Nowinski, C.J.; Stein, T.D.; Alvarez, V.E.; Daneshvar, D.H.; Lee, H.S.; Wojtowicz, S.M.; Hall, G.; Baugh, C.M., et al. The spectrum of disease in chronic traumatic encephalopathy. Brain: J. Neurol. 2013, 136, 43-64.
30. Stern, R.A.; Riley, D.O.; Daneshvar, D.H.; Nowinski, C.J.; Cantu, R.C.; McKee, A.C. Long-term consequences of repetitive brain trauma: Chronic traumatic encephalopathy. Phys. Med. Rehabil. 2011, 3, S460-S467.
31. Gavett, B.; Stern, R.; McKee, A. Chronic traumatic encephalopathy: A potential late effect of sport-related concussive and subconcussive head trauma. Clin. Sports Med. 2011, 30, 179-188.
32. Giunta, B.; Hou, H.; Zhu, Y.; Salemi, J.; Ruscin, A.; Shytle, R.D.; Tan, J. Fish oil enhances anti-amyloidogenic properties of green tea EGCG in Tg 2576 mice. Neurosci. Lett. 2010, 471, 134-138.
33. Smith, A.; Giunta, B.; Bickford, P.C.; Fountain, M.; Tan, J.; Shytle, R.D. Nanolipidic particles improve the bioavailability and alpha-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer's disease. Int. J. Pharm. 2010, 389, 207-212.